Pagina principaleGruppiConversazioniAltroStatistiche
Cerca nel Sito
Questo sito utilizza i cookies per fornire i nostri servizi, per migliorare le prestazioni, per analisi, e (per gli utenti che accedono senza fare login) per la pubblicità. Usando LibraryThing confermi di aver letto e capito le nostre condizioni di servizio e la politica sulla privacy. Il tuo uso del sito e dei servizi è soggetto a tali politiche e condizioni.
Hide this

Risultati da Google Ricerca Libri

Fai clic su di un'immagine per andare a Google Ricerca Libri.

Sto caricando le informazioni...

Bad Blood: Secrets and Lies in a Silicon Valley Startup

di John Carreyrou

Altri autori: Vedi la sezione altri autori.

UtentiRecensioniPopolaritàMedia votiCitazioni
1,7761277,377 (4.29)83
"The full inside story of the breathtaking rise and shocking collapse of a multibillion-dollar startup, by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley"--"The full inside story of the breathtaking rise and shocking collapse of Theranos--the Enron of Silicon Valley--by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in an early fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at the Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley"--… (altro)
Sto caricando le informazioni...

Iscriviti per consentire a LibraryThing di scoprire se ti piacerà questo libro.

Attualmente non vi sono conversazioni su questo libro.

» Vedi le 83 citazioni

Scary things in this book:
*Patients were harmed
*The complete lack of ethics by Elizabeth Holmes and Sunny Balwani and those who enabled them
*The pure sloppiness of those in charge, the employees and the board members
*How many investors and board members would invest millions without doing the due diligence to verify their investments--including George Schulz, Rupert Murdoch, Henry Kissinger, and James Mattis. (I guess if you are a billionaire throwing away $100M is fine).
*How companies such as CVS and Safeway could invest millions in a partnership--even changing their store layout to build wellness centers without due diligence. (I always wondered why my Safeway took floor space away to build what looks like a clinic/spa).
*Why there aren't more protections for employee whistleblowers and maybe we've gone too far with NDA protections if it means this type of fraud can go on for years. ( )
  auldhouse | Sep 30, 2021 |
I listened to the audiobook, and I was pretty entertained by the story.
John Carreyrou has done a great job writing the book, the flow of the story is attracting and I only felt bored a few times in the midst of the book, but focusing on what I was hearing the rest of the time.
( )
  mdibaiee | Sep 23, 2021 |
As I write this review, Elizabeth Holmes is on trial in U.S. federal court for fraud—a situation which is entirely unsurprising, having read John Carreyrou's Bad Blood. At its peak, the tech start-up which she once ran, Theranos, was valued at $9bn, but as Carreyrou shows that valuation was based on nothing more than bullshit.

Much has been made in the media about Holmes' wide-eyed stare, artificially deepened voice, and penchant for cosplaying Steve Jobs. Anecdotes about this crop up quite a bit in Bad Blood. What I found much more interesting—and what I wish Carreyrou had hammered home a bit more—was how much the story of Theranos is an indictment of systemic issues. Holmes is fundamentally a fairly boring, run-of-the-mill sociopath—she wants money and adulation and doesn't much care who she has to step on along the way in order to get it.

But most sociopaths don't end up on the cover of Forbes by the time they're 30. The real story here is that Holmes attended a private high school in Texas and dropped out of Stanford; the people she got to know along the way allowed her to get a Who's Who of terrible human beings to invest in her company, including Henry Kissinger, Rupert Murdoch, the Waltons, and Betsy DeVos. Holmes leveraged the prestige of her expensive education and wealthy connections, the greed of those who valued dollar signs more than human lives, and the anti-intellectual narcissism of those who believe that "disruption" is a greater good than expertise and common sense. In 2021—a year when people are choosing to ingest veterinary-grade dewormers and shit their brains out rather than take a free, safe vaccination—this is the part that resonates more deeply than the schadenfreude of it all. ( )
  siriaeve | Sep 4, 2021 |
Absolutely amazing.... I couldn't believe half of the stuff I read and researched it myself. I am stonished at hw could this happen in this era.... ( )
  Douna1980 | Sep 3, 2021 |
This book should go in the true-crime category, since that is what it is. Truly, it's a shocker. You'll never look at the healthcare industry the same way again. Or at lawyers, for that matter. But then, you never really liked lawyers much, did you? ( )
1 vota booklove54 | Jul 25, 2021 |
nessuna recensione | aggiungi una recensione

» Aggiungi altri autori

Nome dell'autoreRuoloTipo di autoreOpera?Stato
John Carreyrouautore primariotutte le edizionicalcolato
Damron, WillNarratoreautore secondarioalcune edizioniconfermato
Devi effettuare l'accesso per contribuire alle Informazioni generali.
Per maggiori spiegazioni, vedi la pagina di aiuto delle informazioni generali.
Titolo canonico
Dati dalle informazioni generali inglesi. Modifica per tradurlo nella tua lingua.
Titolo originale
Titoli alternativi
Data della prima edizione
Personaggi
Dati dalle informazioni generali inglesi. Modifica per tradurlo nella tua lingua.
Luoghi significativi
Dati dalle informazioni generali inglesi. Modifica per tradurlo nella tua lingua.
Eventi significativi
Dati dalle informazioni generali inglesi. Modifica per tradurlo nella tua lingua.
Film correlati
Dati dalle informazioni generali inglesi. Modifica per tradurlo nella tua lingua.
Premi e riconoscimenti
Dati dalle informazioni generali inglesi. Modifica per tradurlo nella tua lingua.
Epigrafe
Dedica
Dati dalle informazioni generali inglesi. Modifica per tradurlo nella tua lingua.
For Molly, Sebastian, Jack, and Francesca
Incipit
Dati dalle informazioni generali inglesi. Modifica per tradurlo nella tua lingua.
Tim Kemp had good news for his team.
Citazioni
Ultime parole
Dati dalle informazioni generali inglesi. Modifica per tradurlo nella tua lingua.
(Click per vedere. Attenzione: può contenere anticipazioni.)
Nota di disambiguazione
Redattore editoriale
Elogi
Dati dalle informazioni generali inglesi. Modifica per tradurlo nella tua lingua.
Lingua originale
Dati dalle informazioni generali inglesi. Modifica per tradurlo nella tua lingua.
DDC/MDS Canonico
LCC canonico

Risorse esterne che parlano di questo libro

Wikipedia in inglese

Nessuno

"The full inside story of the breathtaking rise and shocking collapse of a multibillion-dollar startup, by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley"--"The full inside story of the breathtaking rise and shocking collapse of Theranos--the Enron of Silicon Valley--by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in an early fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at the Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley"--

Non sono state trovate descrizioni di biblioteche

Descrizione del libro
Riassunto haiku

Copertine popolari

Link rapidi

Voto

Media: (4.29)
0.5
1 8
1.5
2 5
2.5 1
3 58
3.5 29
4 228
4.5 57
5 269

Sei tu?

Diventa un autore di LibraryThing.

 

A proposito di | Contatto | LibraryThing.com | Privacy/Condizioni d'uso | Guida/FAQ | Blog | Negozio | APIs | TinyCat | Biblioteche di personaggi celebri | Recensori in anteprima | Informazioni generali | 163,442,924 libri! | Barra superiore: Sempre visibile